Medisse, a Dutch biomaterial firm, has announced that it has raised €2.6m ($3.5m) in a series B round led by life science investor IIG with participation from existing backers Omnes Capital and University of Leiden-backed BioGeneration Ventures. In addition to the €2.6m ($3.5m), Medisse will also receive an unspecified sum in the form of innovation…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
